Clinuvel Pharmaceuticals 's total assets for Q4 2025 were AU$271.75M, an increase of 15.05% from the previous quarter. AU:CUV total liabilities were AU$30.94M for the fiscal quarter, a 63.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.